Opinion|Videos|July 31, 2024
Navigating CML: Tools to Empower Patients and Caregivers
Joannie Clements, a patient advocate, provides insights on helping newly diagnosed patients with CML and their caregivers navigate the complexities of diagnosis, and Claire Saxton outlines resources available for them.
Advertisement
Episodes in this series
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following questions:
- As a patient advocate, how do you help newly diagnosed CML patients and their caregivers navigate the complexities of the diagnosis and set appropriate care goals? What are some of the biggest challenges patients may face at this stage?
- What resources or educational materials have you found most helpful in supporting newly diagnosed CML patients and their caregivers?
- How do patients typically use these materials? How have you changed your approaches so patients and caregivers can best leverage these materials?
- How do patients typically use these materials? How have you changed your approaches so patients and caregivers can best leverage these materials?
Advertisement
Related to this article
In the phase 2 EVITA trial, vitamin C did not slow clonal growth but was linked to fewer serious adverse events and longer exploratory survival.
FDA approves pirtobrutinib for untreated CLL/SLL without 17p deletion based on BRUIN CLL-313 data. Read key nursing safety takeaways.
Most oral blood cancer drug prescriptions were first rejected by insurers, and fill rates fell sharply when out-of-pocket costs topped $175.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Sunvozertinib Now Available in US for Pretreated EGFR Exon 20+ NSCLC
2
Male Breast Cancer: Managing Endocrine Therapy and Survivorship Care
3
What Oncology Nurses Need to Know About ADCs in Breast Cancer
4
FDA Grants Traditional Approval to Pembrolizumab in TMB-H Solid Tumors
5